Pierre Joseph M, Gandal Michael, Son Maya
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California; Department of Veterans Affairs, VA Greater Los Angeles Healthcare System, Los Angeles, CA.
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California.
Schizophr Res. 2016 Apr;172(1-3):211-2. doi: 10.1016/j.schres.2016.01.056. Epub 2016 Feb 11.
With mounting evidence that the risk of cannabis-induced psychosis may be related to both dose and potency of tetrahydrocannbinol (THC), increasing reports of psychosis associated with cannabinoids containing greater amounts of THC are anticipated. We report two cases of emergent psychosis after using a concentrated THC extract known as cannabis "wax," "oil," or "dabs" raising serious concerns about its psychotic liability. Although "dabbing" with cannabis wax is becoming increasingly popular in the US for both recreational and "medicinal" intentions, our cases raise serious concerns about its psychotic liability and highlight the importance of understanding this risk by physicians recommending cannabinoids for purported medicinal purposes.
随着越来越多的证据表明大麻所致精神病的风险可能与四氢大麻酚(THC)的剂量和效力都有关,预计与含有更高含量THC的大麻素相关的精神病报告将会增加。我们报告了两例在使用一种名为大麻“蜡”、“油”或“浓缩物”的浓缩THC提取物后出现急性精神病的病例,这引发了人们对其导致精神病可能性的严重担忧。尽管在美国,出于娱乐和“药用”目的使用大麻蜡进行“滴吸”越来越普遍,但我们的病例引发了人们对其导致精神病可能性的严重担忧,并凸显了医生在推荐将大麻素用于所谓药用目的时了解这种风险(的重要性)。 (注:原文最后highlight部分翻译时补充了“的重要性”使语句更通顺,符合中文表达习惯,若严格按要求不添加任何解释说明,可表述为:凸显了医生在推荐将大麻素用于所谓药用目的时了解这种风险)